Ganoderic acid A exerts antitumor activity against MDA‑MB‑231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway

Yuguang Yang(Peking University), Qingyuan Zhang(Jiangxi University of Traditional Chinese Medicine)

Oncology Letters

September 21, 2018

10.3892/ol.2018.9475

Cited by 44

Related Papers

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

|Journal of Clinical Oncology|2021|350

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

|BMJ|2023|82

The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte

|Cancer Immunology Immunotherapy|2021|51